Clinical Trial Update: Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating papaverine in combination with chemoradiation for stage II-III non-small cell lung cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Papaverine (papaverine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | Phase 1 | Status: RECRUITING